Massachusetts Financial Services’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $163M | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $21.5M | Sell |
|
|||||
|
2023
Q3 | $122M | Buy |
|
|||||
|
2023
Q2 | $128M | Sell |
|
|||||
|
2023
Q1 | $153M | Buy |
|
|||||
|
2022
Q4 | $180M | Buy |
|
|||||
|
2022
Q3 | $107M | Buy |
|
|||||
|
2022
Q2 | $50.2M | Buy |
|
|||||
|
2022
Q1 | $49.4M | Sell |
|
|||||
|
2021
Q4 | $224M | Sell |
|
|||||
|
2021
Q3 | $258M | Sell |
|
|||||
|
2021
Q2 | $233M | Sell |
|
|||||
|
2021
Q1 | $206M | Sell |
|
|||||
|
2020
Q4 | $229M | Sell |
|
|||||
|
2020
Q3 | $277M | Buy |
|
|||||
|
2020
Q2 | $157M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $5.29M | Buy |
|
|||||
|
2016
Q2 | $4.29M | Sell |
|
|||||
|
2016
Q1 | $5.02M | Buy |
|
|||||
|
2015
Q4 | $7.44M | Sell |
|
|||||
|
2015
Q3 | $6.39M | Sell |
|
|||||
|
2015
Q2 | $9.71M | Sell |
|
|||||
|
2015
Q1 | $8.59M | Buy |
|
|||||
|
2014
Q4 | $7.73M | Buy |
|